D.E. Shaw & Co’s Immunic IMUX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-52,275
| Closed | -$69K | – | 3317 |
|
|
2024
Q1 | $69K | Buy |
+52,275
| New | +$69K | ﹤0.01% | 2847 |
|
|
2022
Q4 | – | Sell |
-56,977
| Closed | -$180K | – | 3691 |
|
|
2022
Q3 | $180K | Buy |
56,977
+6,284
| +12% | +$19.9K | ﹤0.01% | 3236 |
|
|
2022
Q2 | $176K | Sell |
50,693
-15,132
| -23% | -$52.5K | ﹤0.01% | 3428 |
|
|
2022
Q1 | $744K | Buy |
+65,825
| New | +$744K | ﹤0.01% | 3029 |
|
|
2018
Q3 | – | Sell |
-1,123
| Closed | -$308K | – | 2610 |
|
|
2018
Q2 | $308K | Buy |
1,123
+756
| +206% | +$207K | ﹤0.01% | 2317 |
|
|
2018
Q1 | $100K | Sell |
367
-898
| -71% | -$245K | ﹤0.01% | 2425 |
|
|
2017
Q4 | $301K | Buy |
1,265
+155
| +14% | +$36.9K | ﹤0.01% | 2273 |
|
|
2017
Q3 | $224K | Buy |
1,110
+36
| +3% | +$7.27K | ﹤0.01% | 2316 |
|
|
2017
Q2 | $125K | Sell |
1,074
-475
| -31% | -$55.3K | ﹤0.01% | 2307 |
|
|
2017
Q1 | $248K | Sell |
1,549
-107
| -6% | -$17.1K | ﹤0.01% | 2224 |
|
|
2016
Q4 | $288K | Buy |
1,656
+202
| +14% | +$35.1K | ﹤0.01% | 2237 |
|
|
2016
Q3 | $356K | Buy |
1,454
+287
| +25% | +$70.3K | ﹤0.01% | 2140 |
|
|
2016
Q2 | $289K | Buy |
1,167
+283
| +32% | +$70.1K | ﹤0.01% | 2253 |
|
|
2016
Q1 | $321K | Buy |
884
+416
| +89% | +$151K | ﹤0.01% | 2222 |
|
|
2015
Q4 | $215K | Buy |
+468
| New | +$215K | ﹤0.01% | 2402 |
|
|
2015
Q3 | – | Sell |
-2,039
| Closed | -$1.72M | – | 2606 |
|
|
2015
Q2 | $1.72M | Buy |
2,039
+149
| +8% | +$126K | ﹤0.01% | 1551 |
|
|
2015
Q1 | $1.89M | Buy |
1,890
+455
| +32% | +$455K | ﹤0.01% | 1401 |
|
|
2014
Q4 | $1.43M | Buy |
+1,435
| New | +$1.43M | ﹤0.01% | 1528 |
|